Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dar Aldawa Dv/Iv | Amman | Healthcare | Pharmaceuticals | JOD 44.45M | 13.2x | 0.88 | JOD 1.27 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Consulting Group | Amman | Healthcare | Healthcare Providers & Services | JOD 36.40M | 27.2x | 0.44 | JOD 1.82 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hayat Phat | Amman | Healthcare | Pharmaceuticals | JOD 27.84M | 9x | 0.27 | JOD 2.93 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ibn Alhaytham H. | Amman | Healthcare | Healthcare Providers & Services | JOD 14M | 175x | 1.67 | JOD 0.70 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Philadelphia Pharma Industry | Amman | Healthcare | Pharmaceuticals | JOD 10.80M | 13.1x | 7.41 | JOD 1.44 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |